![Mark Vignola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Vignola
No open positions remaining
Profile
Mark J.
Vignola formerly worked at Lehman Brothers, Inc., as Analyst in 2000, Intercept Pharmaceuticals, Inc., as Head-Corporate Development from 2018 to 2019, Needham & Co. LLC, as Equity Research Associate from 2011 to 2015, Duke University Medical Center, as Research Assistant in 2011, Applied Therapeutics, Inc., as Chief Financial Officer from 2019 to 2020, and Terns Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer from 2021 to 2025.
Dr. Vignola received his graduate degree in 2002 from Duke University, undergraduate degree in 1999 from Boston College, and doctorate degree from Duke University School of Medicine.
Former positions of Mark Vignola
| Companies | Position | End |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Director of Finance/CFO | 2025-01-31 |
| APPLIED THERAPEUTICS, INC. | Director of Finance/CFO | 2020-04-30 |
| INTERCEPT PHARMACEUTICALS, INC. | Investor Relations Contact | 2019-04-30 |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2015-04-30 |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2010-12-31 |
Training of Mark Vignola
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
- Stock Market
- Insiders
- Mark Vignola
